PCVX — VAXCYTE INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying PCVX?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 2 tracked investors who changed their PCVX position last quarter, 1 bought and 1 sold (50% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 55/100 in a Contraction regime). 2 congressional purchases, 0 sales disclosed in the last 6 months.
- +1 tracked investor added or increased positions last quarter (Ray Dalio)
- +4 tracked investors reported holding PCVX at their latest filing
- +Macro Health is 55/100 in a Contraction regime — historically acceptable for this sectorsource
- +2 congressional purchases disclosed in the last 6 months
- −1 tracked investor reduced or exited last quarter (0 reduced, 1 sold out)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/17/2026.
About VAXCYTE INC (PCVX)
VAXCYTE INC (PCVX) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Seth Klarman (Baupost Group), valued at $46M. Across recent filings, tracked investors recorded 4 new positions, 2 increased, 0 reduced, and 3 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in PCVX
How many top investors track PCVX
A small number of top investors own this.
PCVX Ownership Composition
How VAXCYTE INC is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant85.7%
- Macro14.3%
Tracked investors currently reporting PCVX
3 tracked investors have since exited this position — listed separately below.
- Ken GriffinJun 30, 2026Citadel AdvisorsShares358.1KValue$20.8M% Portfolio0.00%
- Izzy EnglanderJun 30, 2026Millennium ManagementShares136.6KValue$7.9M% Portfolio0.00%
- Paul Tudor JonesJun 30, 2026Tudor Investment CorpShares32.1KValue$1.9M% Portfolio0.00%
- Ray DalioJun 30, 2026Bridgewater AssociatesShares50.2KValue$2.9M% Portfolio0.01%
Previously held PCVX
These investors reported PCVX in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Seth Klarman | Baupost Group | 800K | $46.5M | Mar 31, 2026 |
| Steve Cohen | Point72 Asset Management | 620.4K | $36.1M | Mar 31, 2026 |
| Stanley Druckenmiller | Duquesne Family Office | 86.3K | $7.1M | Dec 31, 2024 |
Recent activity
- New$46.5MMay 14, 2026
- Sold$0(-100.00%)Aug 13, 2026
- New$427KNov 13, 2025
- Sold$0(-100.00%)Feb 13, 2026
- New$749.8KMay 15, 2026
- Increased$2.9M(289.19%)Aug 14, 2026
- $4.9MNov 14, 2024
- Increased$7.1M(100.78%)Feb 14, 2025
- $0(-100.00%)May 15, 2025
Frequently asked questions
- How many institutional investors hold PCVX?
- 4 tracked institutional investors disclosed a position in PCVX (VAXCYTE INC) in their most recent 13F filing.
- Who is the largest institutional holder of PCVX?
- Seth Klarman, Baupost Group, holds the largest disclosed position in PCVX, valued at $46M.
- Did institutional ownership of PCVX increase or decrease?
- Across recent 13F filings, tracked investors recorded 4 new positions, 2 increased, 0 reduced, and 3 fully exited PCVX.
- Where does this PCVX ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.